Vanguard Capital Management
IONS icon

Vanguard Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Vanguard Capital Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$572M Buy
7,211,497
+93,167
+1% +$7.01M 0.01% 659
2026
Q1 		$535M Buy
+7,118,330
New +$562M 0.01% 649

Other funds holding IONS

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management's IONS Position: Q2 2026 in Review

Vanguard Capital Management increased its Ionis Pharmaceuticals (IONS) stake by 1.3% in Q2 2026, buying an estimated $7.01M and bringing the position to 7,211,497 shares worth $572M. The position accounts for 0.01% of the portfolio, ranked #659.

Vanguard Capital Management first reported a position in IONS in Q1 2026 and has held it in 2 quarters since. 477 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Vanguard Capital Management held 7,211,497 shares of Ionis Pharmaceuticals worth $572M as of Q2 2026.
  • Vanguard Capital Management bought 93,167 Ionis Pharmaceuticals shares in Q2 2026, an estimated $7.01M.
  • Ionis Pharmaceuticals made up 0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #659 holding.
  • Vanguard Capital Management first reported a position in Ionis Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 477 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.